OTC Markets OTCQX - Delayed Quote USD
Sandoz Group AG (SDZNY)
42.40
+0.03
+(0.07%)
At close: April 25 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Richard Saynor | Chief Executive Officer | 4.56M | -- | 1967 |
| Mr. Remco J. Steenbergen | Chief Financial Officer | 2.27M | -- | 1968 |
| Mr. Asaf Gal | Chief Technology Officer | -- | -- | 1969 |
| Ms. Claire D'Abreu-Hayling | Chief Scientific Officer | -- | -- | 1964 |
| Laurent de Weck | Head Investor Relations | -- | -- | -- |
| Ms. Ingrid Sollerer | General Counsel & Chief Compliance Officer | -- | -- | 1974 |
| Ms. Tripti Jha | Chief People Officer | -- | -- | 1977 |
| Dr. Glenn A. Gerecke Ph.D. | Chief Manufacturing & Supply Officer | -- | -- | 1959 |
| Ms. Rebecca Guntern | Chief Commercial Officer | -- | -- | 1972 |
| Ms. Keren Haruvi | President of North America | -- | -- | 1980 |
Sandoz Group AG
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 22,049
Description
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
Corporate Governance
Sandoz Group AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 5, 2025 at 6:00 AM UTC
Sandoz Group AG Earnings Date
Recent Events
April 22, 2025 at 12:00 AM UTC
Ex-Dividend Date
June 18, 2024 at 12:00 AM UTC
Dividend Date
Related Tickers
TAK Takeda Pharmaceutical Company Limited
15.03
-0.53%
AGYTF Allergy Therapeutics plc
0.0850
0.00%
BIOGY BioGaia AB (publ)
10.81
0.00%
HLNCF Haleon plc
5.03
-3.08%
GALDY GALDERMA GROUP AG
22.82
0.00%
BNXTF BioNxt Solutions Inc.
0.3400
0.00%
FH.NE Filament Health Corp.
0.0250
-28.57%
2196.HK Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
14.840
+0.27%
HLN Haleon plc
10.18
-0.13%
RDY Dr. Reddy's Laboratories Limited
13.79
-1.50%